Drugplain

NDC 66215-602-06

UPTRAVI 200 ug/1

Selexipag · TABLET, COATED

No Recall History

UPTRAVI is a tablet, coated containing selexipag at a strength of 200 ug/1. Manufactured by Actelion Pharmaceuticals US, Inc..

Key Facts

Brand Name
UPTRAVI
Generic Name
Selexipag
NDC Code (Package)
66215-602-06
NDC Code (Product)
66215-602
Manufacturer
Actelion Pharmaceuticals US, Inc.
Strength
200 ug/1
Dosage Form
TABLET, COATED
Route
ORAL
Marketing Status
Application #
NDA207947
Marketing Start
12/21/2015

Recall History

No Recall History

View Full Drug Page

UPTRAVI — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.